Shustik J. Unique Toxicities of Novel Myeloma Therapies: Focus on Belantamab Mafodotin, Talquetamab, and Selinexor. Can Hematol Today [Internet]. 2025 Dec. 8 [cited 2025 Dec. 12];4(3):24–35. Available from: https://canadianhematologytoday.com/article/view/4-3-Shustik